4.8 Letter

Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial: Insight From the Veterans Affairs Healthcare System

期刊

CIRCULATION
卷 139, 期 10, 页码 1341-1343

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.118.038691

关键词

icosapent ethyl

资金

  1. Department of Veterans Affairs Health Services Research & Development Service Investigator Initiated Grant [IIR 16-072]
  2. American Heart Association [14BGIA20460366]
  3. American Diabetes Association Clinical Science and Epidemiology award [1-14-CE-44]
  4. Houston VA Health Services Research & Development Center for Innovations grant [CIN13-413]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据